HB 1456 Summary

• Exempts gross receipts from sales of tangible personal property purchased for direct and predominant use in bioscience and biotechnology research and development from North Dakota sales and use tax.

• Requires qualified biotechnology and bioscience taxpayers to obtain a certificate from the tax commissioner before purchase to claim exemption at point of sale; allows refund applications if certificate not obtained prior to purchase.

• Defines "bioscience" as cellular and molecular research and manufacturing in pharmaceuticals, medical therapeutics, diagnostics, devices, biochemistry, microbiology, veterinary medicine, plant biology, and agriculture and industrial applications.

• Defines "biotechnology" as application of technologies to produce or modify products, develop microorganisms, identify pharmaceutical targets, or transform biological systems for human or animal health care improvements.

• Effective for taxable events occurring after June 30, 2021.